{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:55:45Z","timestamp":1760147745668,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.arth.2022.04.027","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T23:26:28Z","timestamp":1650929188000},"page":"1870-1878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antiviral Treatment for Hepatitis C Is Associated With a Reduced Risk of Periprosthetic Joint Infection: A Meta-Analysis of Observational Studies"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4855-0020","authenticated-orcid":false,"given":"Tao","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongdong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixiao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2022.04.027_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.arth.2020.08.023","article-title":"Prevalence of hepatitis C virus infection in the veteran population undergoing total joint arthroplasty: an update","volume":"36","author":"Shapiro","year":"2021","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.04.027_bib2","doi-asserted-by":"crossref","first-page":"e20.00223","DOI":"10.2106\/JBJS.RVW.20.00223","article-title":"Perioperative management of hepatitis C in patients undergoing total joint arthroplasty","volume":"9","author":"Ross","year":"2021","journal-title":"JBJS Rev"},{"key":"10.1016\/j.arth.2022.04.027_bib3","first-page":"E117","article-title":"Risk of hepatitis C virus exposure in orthopedic surgery: is universal screening needed?","volume":"43","author":"DelSole","year":"2014","journal-title":"Am J Orthop (Belle Mead Nj)"},{"key":"10.1016\/j.arth.2022.04.027_bib4","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2106\/JBJS.O.00183","article-title":"The impact of hepatitis C on short-term outcomes of total joint arthroplasty","volume":"97","author":"Issa","year":"2015","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2022.04.027_bib5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jos.2018.12.026","article-title":"Does the hepatitis C virus affect the outcomes of total joint arthroplasty? A meta-analysis of ten studies","volume":"24","author":"Wei","year":"2019","journal-title":"J\u00a0Orthop Sci"},{"key":"10.1016\/j.arth.2022.04.027_bib6","doi-asserted-by":"crossref","first-page":"102947","DOI":"10.1016\/j.otsr.2021.102947","article-title":"Hepatitis C virus infection increases the risk of adverse outcomes following joint arthroplasty: a meta-analysis of observational studies","volume":"108","author":"Cheng","year":"2022","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.arth.2022.04.027_bib7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.arth.2014.11.013","article-title":"Increase in perioperative complications following primary total hip and knee arthroplasty in patients with hepatitis C without cirrhosis","volume":"30","author":"Best","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.04.027_bib8","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.5435\/JAAOS-D-16-00920","article-title":"Complication rates after total hip and knee arthroplasty in patients with hepatitis C compared with matched control patients","volume":"25","author":"Cancienne","year":"2017","journal-title":"J\u00a0Am Acad Orthop Surg"},{"key":"10.1016\/j.arth.2022.04.027_bib9","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.arth.2017.04.001","article-title":"Does hepatitis C affect the clinical and patient-reported outcomes of primary total hip arthroplasty at midterm follow-up?","volume":"32","author":"Issa","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.04.027_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.arth.2013.03.023","article-title":"Fibrosis in hepatitis C patients predicts complications after elective total joint arthroplasty","volume":"29","author":"Orozco","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.04.027_bib11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1302\/0301-620X.101B6.BJJ-2018-0723.R3","article-title":"The preoperative management of Hepatitis C may improve the outcome after total knee arthroplasty","volume":"101-B","author":"Schwarzkopf","year":"2019","journal-title":"Bone Joint J"},{"key":"10.1016\/j.arth.2022.04.027_bib12","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.arth.2019.06.058","article-title":"Undetectable hepatitis C viral load is associated with improved outcomes following total joint arthroplasty","volume":"34","author":"Novikov","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.04.027_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.arth.2021.12.023","article-title":"A\u00a0missed opportunity; the impact of hepatitis C treatment prior to total knee arthroplasty on postoperative complications","volume":"37","author":"Ross","year":"2022","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.04.027_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.arth.2018.09.036","article-title":"Treatment for chronic hepatitis C prior to total hip arthroplasty significantly reduces periprosthetic joint infection","volume":"34","author":"Bedair","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.04.027_bib15","doi-asserted-by":"crossref","first-page":"S319","DOI":"10.1016\/j.arth.2019.02.052","article-title":"Preoperative treatment of hepatitis C is associated with lower prosthetic joint infection rates in US Veterans","volume":"34","author":"Bendich","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.04.027_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jseint.2021.02.009","article-title":"Hepatitis C infection and complication rates after total shoulder arthroplasty in United States veterans","volume":"5","author":"Su","year":"2021","journal-title":"JSES Int"},{"key":"10.1016\/j.arth.2022.04.027_bib17","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.arth.2020.12.025","article-title":"Hepatitis C antiviral treatment decreases all-cause complications after total joint arthroplasty regardless of the presence of fibrosis","volume":"36","author":"Cornell","year":"2021","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.04.027_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2022.02.102","article-title":"Does preoperative antiviral treatment for hepatitis C decrease risk of complications after total hip arthroplasty? A matched cohort study","author":"Ross","year":"2022","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.04.027_bib19","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PloS Med"},{"key":"10.1016\/j.arth.2022.04.027_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J\u00a0Epidemiol Community Health"},{"key":"10.1016\/j.arth.2022.04.027_bib21","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/liv.14469","article-title":"Frequent loss to follow-up after diagnosis of hepatitis C virus infection: a barrier towards the elimination of hepatitis C virus","volume":"40","author":"Aleman","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.arth.2022.04.027_bib22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.14324","article-title":"Global timing of hepatitis C virus elimination in high-income countries","volume":"40","author":"Razavi","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.arth.2022.04.027_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000501821","article-title":"Identifying barriers to the treatment of chronic hepatitis C infection","volume":"38","author":"Al-Khazraji","year":"2020","journal-title":"Dig Dis"},{"key":"10.1016\/j.arth.2022.04.027_bib24","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.arth.2012.05.016","article-title":"Prevalence of hepatitis C virus infection in the veteran population undergoing total joint arthroplasty","volume":"27","author":"Calore","year":"2012","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.04.027_bib25","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.3390\/v13112249","article-title":"A\u00a0Review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy","volume":"13","author":"Mazzaro","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.arth.2022.04.027_bib26","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1007\/s11999-016-4979-9","article-title":"Is hepatitis C infection associated with a higher risk of complications after total shoulder arthroplasty?","volume":"474","author":"Cancienne","year":"2016","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2022.04.027_bib27","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.arth.2017.10.061","article-title":"Short and long-term postoperative complications following total joint arthroplasty in patients with human immunodeficiency virus, hepatitis B, or hepatitis C","volume":"33","author":"Kildow","year":"2018","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.04.027_bib28","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/jgh.12837","article-title":"Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma","volume":"30","author":"Caviglia","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.arth.2022.04.027_bib29","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.5435\/JAAOS-D-16-00635","article-title":"Strategies to prevent periprosthetic joint infection after total knee arthroplasty and lessen the risk of readmission for the patient","volume":"25","author":"Iorio","year":"2017","journal-title":"J\u00a0Am Acad Orthop Surg"},{"key":"10.1016\/j.arth.2022.04.027_bib30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s11739-018-1828-8","article-title":"Direct-acting antiviral drugs for chronic hepatitis C and risk of major vascular events: a systematic review","volume":"13","author":"Tamborini Permunian","year":"2018","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.arth.2022.04.027_bib31","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.arth.2018.05.007","article-title":"Primary hip and knee arthroplasty in a safety net hospital: substance abuse and other factors affecting short-term complications","volume":"33","author":"Jergesen","year":"2018","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.04.027_bib32","article-title":"Movement is life-optimizing patient access to total joint arthroplasty: HIV and hepatitis C disparities","author":"Wiznia","year":"2021","journal-title":"J\u00a0Am Acad Orthop Surg"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540322004764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540322004764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:42:07Z","timestamp":1760121727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540322004764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0883540322004764"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2022.04.027","relation":{},"ISSN":["0883-5403"],"issn-type":[{"type":"print","value":"0883-5403"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral Treatment for Hepatitis C Is Associated With a Reduced Risk of Periprosthetic Joint Infection: A Meta-Analysis of Observational Studies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2022.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}